NattoPharma
  • Home
  • About
    • About NattoPharma
    • Corporate Strategy
    • The NattoPharma Team
    • Board of Directors
  • Investor Relations
    • Share Information
      • Share Price
      • 20 Largest Shareholders
      • Analyst Coverage
      • Primary Insiders
    • Reports & Company Announcements
      • Reports & Presentations
      • Financial Calendar
      • Press Releases
      • Contacts
    • Information for Shareholders
      • Annual General Meeting
      • Dividend Policy
      • Prospectus
      • Registrar & Auditor
    • Corporate Governance
      • Articles of Association
      • Code of Conduct & Corporate Social Responsibility
  • R & D
    • Scientific Substantiation
    • Regulatory & IP
    • Patents
  • Brands & Services
    • Health Solutions
    • MenaQ7
    • Marketing & Sales Support
  • News & Media
    • Latest News
    • Event Calendar
    • Videos
    • Press Room
  • Contact
Select Page

Prospectus

Prospectuses issued last three years:

Prospectus dated April 10th 2015

Supplement prospectus dated April 24th 2015

Main Office:


Lilleakerveien 2B, 0283
Oslo, Norway


Phone: (+47) 40 00 90 08

NattoPharma R&D Ltd.


75 Prodromou Street
1st floor, office 101
Strovolos
2063 Nicosia
Cyprus

N. American Subsidiary:


5 Joanna Court
East Brunswick, NJ 08816


Phone: (+1) 609-454-2992

Legal


Privacy Policy
Terms of Use
Sitemap
Contact Us


Join Us
© 2017 NattoPharma® All rights reserved.
Web site designed by Market3 LLC, a NJ Web Design Firm